Definitive Analysis
Financial Statements
Company Industry Sector
Periods / Units
Fundamentals
Margins Returns Growth Rates Metrics/Ratios
Valuations
Projections DCF DDM EPV Multiples Valuations
Miscellaneous
Indicators Charts WACC Beta Predictability
Analysis Mode
Full Access
See Pricing Start Trial
Multiples Valuation: Consun Pharmaceutical Group Limited

Consun Pharmaceutical Group Limited (1681.HK)

Industry: Drug Manufacturers - Specialty & Generic Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $26.25 — $41.63
Selected (Average) $33.52
Upside to Live 94.22%
Full Range Fair Value
Range (Low - High) $30.10 — $52.23
Selected (Average) $39.28
Upside to Live 127.58%
Live Price $17.26

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
000423.SZ 93 Dong-E-E-Jiao Co., 902 18.14 18.14 12.38 12.38 13.73 12.88
600195.SS 94 China Animal Husba 891 34.10 39.87 19.00 19.42 124.26 98.25
0IRF.IL 95 Evotec SE 888 - - - - - -
600789.SS 96 Shandong Lukang Ph 879 46.33 49.00 19.25 16.86 82.59 46.97
600566.SS 97 Hubei Jumpcan Phar 872 13.47 12.80 9.22 8.92 13.11 8.85
4569.T 98 KYORIN Holdings, I 859 9.12 8.71 5.30 4.99 - 7.03
002262.SZ 99 Jiangsu Nhwa Pharm 855 22.43 20.12 18.55 16.72 15.29 17.03
1681.HK 100 Consun Pharmaceuti 852 4.81 3.59 3.29 2.50 3.19 2.48
T14.SI 101 Tianjin Pharmaceut 851 3.85 2.71 2.39 1.72 1.34 1.72
605507.SS 102 Guobang Pharma Ltd 843 14.46 14.46 10.44 10.44 14.23 13.29
JUBLPHARMA.BO 103 Jubilant Pharmova 843 35.79 39.44 16.10 17.17 20.45 10.08
ANIP 104 ANI Pharmaceutical 827 33.98 33.98 8.53 5.71 15.29 23.85
TSPC.JK 105 PT Tempo Scan Paci 814 7.12 5.99 3.05 2.66 3.25 3.61
EBS 106 Emergent BioSoluti 789 6.18 7.23 4.11 4.64 2.90 8.71
APLLTD.BO 107 Alembic Pharmaceut 784 27.93 31.14 17.08 18.16 19.89 8.68
300026.SZ 108 Tianjin Chase Sun 779 - - 47.13 61.31 47.02 -

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple14.4614.469.839.6814.238.85
Full Range Median Multiple18.1418.1411.4111.4115.2910.08
Industry Multiple20.9921.8113.7514.3628.7220.07
Market Implied Multiple8.045.996.144.665.964.63
Company (1681.HK) Multiple4.813.593.292.503.192.48
(*) Net Income / EBITDA / Revenue262351297391306394
Winsorized Enterprise ValueN/AN/A2,9193,7834,3493,483
Full Range Median Enterprise ValueN/AN/A3,3884,4604,6733,967
(-) Net Debt-282-282-282-282-282-282
Winsorized Equity Value3,7865,0763,2014,0664,6323,766
Full Range Median Equity Value4,7516,3693,6714,7424,9564,249
(/) Shares Outstanding122122122122122122
Winsorized Fair Value$31.05$41.63$26.25$33.34$37.98$30.88
Full Range Median Fair Value$38.96$52.23$30.10$38.89$40.64$34.85
Current Price$17.26$17.26$17.26$17.26$17.26$17.26
Upside / Downside79.90%141.17%52.11%93.17%120.07%78.92%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$21.74$29.14$18.38$23.34$26.59$21.62
Buy / Don't BuyBUYBUYBUYBUYBUYBUY